Skip to main content

DaVita Inc.

corporate_fare Company Profile

DaVita Inc.

DVA·NYSE·Life Sciences·CIK 0000927066

DaVita Inc. is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. The company is a comprehensive kidney care provider and has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey, from slowing the progression of kidney disease to helping support transplantation. This includes supporting patients at home, in their dialysis centers, in the hospital, and in skilled nursing facilities. The company's mission is to be the provider, partner, and employer of choice. Chronic kidney disease (CKD) has five stages, generally based on how well the kidneys filter waste and extra fluid from the blood. Higher stages of CKD correspond to progressing levels of kidney disease. Stage 1 CKD is the closest to healthy kidney function, while Stage 5 CKD indicates severe kidney damage.

DaVita Inc. (NYSE:DVA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for DVA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for DVA spans 10-Q, 8-K, 4, 144.

Recent high-impact activity:

  • Washington State Sues DaVita, Fresenius Over Nephrologist Noncompetes
  • DaVita 10-Q Details Q3 EPS of $3.40, $62M China Impairment and $862M of Buybacks
  • DaVita Q3 EPS $3.40, Adjusted $3.82; 2026 EPS Guidance Narrowed to $14.30-$15.20
  • DaVita Posts 3Q Adjusted EPS of $3.82
  • DaVita Wins Preliminary Approval for Ransomware Class Action Settlement

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$13.64B
Net Income
$746.8M
Diluted EPS
$9.84
Op. Cash Flow
$1.89B
Free Cash Flow
$1.31B
Operating Income
$2.04B
Cash & Equivalents
$676.44M
Debt / Equity
0.00×
Net Margin
5.5%
Shares Outstanding
68.55M sh
Source: 10-K · filed 2026-02-11 · accession 0000927066-26-000012

Short Interest & Short Volume

5.14 days to cover

FINRA reported short interest of 5,141,769 shares in DVA as of the October 30, 2026 settlement, a 4.8% increase from the prior period — about 5.1 days to cover at its recent average daily volume. On November 20, 2026, 65.5% of DVA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,141,769 shares as of October 30, 2026
Change vs prior period▲ 4.8%
Days to cover5.14 at avg daily volume of 1,000,667
Daily short volume (FINRA facilities)65.5% of 290,422 shares on November 20, 2026
5-day average short volume78.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with D →
$161.03
52-week range · as of 2026-10-29 $101 – $247.49
Market cap
$10.13B
Volume
730.2K (0.9× avg)
3-mo avg 831K
Live data · 2026-11-22 12:35 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DVA - Latest Insights

DVA
Nov 10, 2026, 12:42 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $180.24
Real-time Price: $161.03 info
Change: -$19.21 (-11%) info
Market Cap: $10.129B info
DVA
Oct 29, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $180.00
Real-time Price: $161.03 info
Change: -$18.97 (-11%) info
Market Cap: $10.129B info
DVA
Oct 29, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $184.00
Real-time Price: $161.03 info
Change: -$22.97 (-12%) info
Market Cap: $10.129B info
DVA
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $193.31
Real-time Price: $161.03 info
Change: -$32.28 (-17%) info
Market Cap: $10.129B info
DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $161.03 info
Change: -$21.67 (-12%) info
Market Cap: $10.129B info
DVA
Aug 25, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $176.50
Real-time Price: $161.03 info
Change: -$15.47 (-9%) info
Market Cap: $10.129B info
DVA
Aug 04, 2026, 4:36 PM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $214.99
Real-time Price: $161.03 info
Change: -$53.96 (-25%) info
Market Cap: $10.129B info
DVA
Aug 04, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $218.00
Real-time Price: $161.03 info
Change: -$56.97 (-26%) info
Market Cap: $10.129B info
DVA
Aug 04, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $211.90
Real-time Price: $161.03 info
Change: -$50.87 (-24%) info
Market Cap: $10.129B info
DVA
Jun 17, 2026, 6:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $210.58
Real-time Price: $161.03 info
Change: -$49.55 (-24%) info
Market Cap: $10.129B info
DVA
Jun 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $208.98
Real-time Price: $161.03 info
Change: -$47.95 (-23%) info
Market Cap: $10.129B info
DVA
Jun 08, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $192.08
Real-time Price: $161.03 info
Change: -$31.05 (-16%) info
Market Cap: $10.129B info
DVA
Jun 08, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $192.08
Real-time Price: $161.03 info
Change: -$31.05 (-16%) info
Market Cap: $10.129B info
DVA
May 05, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $163.00
Real-time Price: $161.03 info
Change: -$1.97 (-1%) info
Market Cap: $10.129B info
DVA
May 05, 2026, 4:21 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $159.61
Real-time Price: $161.03 info
Change: +$1.42 (+0.89%) info
Market Cap: $10.129B info
DVA
May 05, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $162.00
Real-time Price: $161.03 info
Change: -$0.970 (-0.60%) info
Market Cap: $10.129B info
DVA
Apr 02, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $146.40
Real-time Price: $161.03 info
Change: +$14.63 (+10%) info
Market Cap: $10.129B info
DVA
Feb 11, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $144.27
Real-time Price: $161.03 info
Change: +$16.76 (+12%) info
Market Cap: $10.129B info
DVA
Feb 02, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $115.90
Real-time Price: $161.03 info
Change: +$45.13 (+39%) info
Market Cap: $10.129B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets